These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35836098)

  • 1. Discovery of novel α-carboline derivatives as glycogen synthase kinase-3β inhibitors for the treatment of Alzheimer's disease.
    Chen H; Yu C; Liu W; Zhu C; Jiang X; Xu C; Liu W; Huang Y; Xu Z; Zhao Q
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200156. PubMed ID: 35836098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.
    Liu W; Tian L; Wu L; Chen H; Wang N; Liu X; Zhao C; Wu Z; Jiang X; Wu Q; Xu Z; Liu W; Zhao Q
    Bioorg Chem; 2022 Dec; 129():106168. PubMed ID: 36191431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
    Qiu J; Feng X; Chen H; Liu W; Liu W; Wu L; Gao X; Liu Y; Huang Y; Gong H; Qi Y; Xu Z; Zhao Q
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300404. PubMed ID: 38010470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
    Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
    Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
    Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
    Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of thieno[3,2-
    Yan N; Shi XL; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1724-1736. PubMed ID: 35698879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
    J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Bio-evaluation and Molecular Dynamics Simulation of Novel GSK-3β Inhibitors.
    Lyu W; Li Q; Li Q; Chen Y; Wang Y; Tang T; Feng F; Chi H; Li Y; Liu W; Sun H
    Mol Inform; 2021 Dec; 40(12):e2060031. PubMed ID: 34323388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer's disease.
    Yan N; Xie F; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    Bioorg Chem; 2023 Sep; 138():106663. PubMed ID: 37329814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of natural compounds by virtual screening, molecular docking and dynamics studies and evaluation of their effects on tau level
    Uzunhisarcıklı E; Çelik İ; Yerer MB
    J Biomol Struct Dyn; 2024; 42(1):384-392. PubMed ID: 36946204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
    Li J; Chen W; Yi Y; Tong Q
    J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
    Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
    Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
    J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration.
    Zhou Q; Li S; Li M; Ke D; Wang Q; Yang Y; Liu GP; Wang XC; Liu E; Wang JZ
    EBioMedicine; 2022 Apr; 78():103970. PubMed ID: 35339896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
    Duka T; Duka V; Joyce JN; Sidhu A
    FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.
    Lin CH; Hsieh YS; Wu YR; Hsu CJ; Chen HC; Huang WH; Chang KH; Hsieh-Li HM; Su MT; Sun YC; Lee GC; Lee-Chen GJ
    Eur J Pharm Sci; 2016 Jun; 89():11-9. PubMed ID: 27094783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.